- Home
- NTSK vs MMED Comparison
NTSK vs MMED Comparison
Compare NTSK & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NTSK | MMED |
|---|---|---|
| Founded | 2012 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 4.7B |
| IPO Year | 2025 | 2025 |
Fundamental Metrics
Financial Performance| Metric | NTSK | MMED |
|---|---|---|
| Price | $21.55 | $18.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 16 |
| Target Price | $20.82 | ★ $25.33 |
| AVG Volume (30 Days) | 6.1M | ★ 8.6M |
| Earning Date | 12-02-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 12.64 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $708,997,000.00 | ★ $3,102,000,000.00 |
| Revenue This Year | $25.60 | $10.76 |
| Revenue Next Year | $21.15 | $8.51 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 31.72 | 14.25 |
| 52 Week Low | $7.67 | $10.65 |
| 52 Week High | $26.71 | $24.43 |
Technical Indicators
Market Signals| Indicator | NTSK | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 49.79 | 47.68 |
| Support Level | $20.73 | $16.61 |
| Resistance Level | $26.71 | $20.40 |
| Average True Range (ATR) | 1.71 | 0.95 |
| MACD | -0.40 | 0.02 |
| Stochastic Oscillator | 16.64 | 45.31 |
Price Performance
Historical ComparisonAbout NTSK Netskope Inc.
Netskope Inc is redefining the security and networking of cloud and AI. The company has formed a cloud-native platform that offers converged security, networking services, and analytics technology stack to enable fast and secure AI, cloud, and web access at the edge. The products of the company include Netskope One SASE, Netskope One SSE, Cloud Access Security Broker (CASB), Next Generation Secure Web Gateway (SWG), Private Access, Cloud Firewall, SD-WAN, SkopeAI, and others.
About MMED MiniMed Group Inc. Common Stock
While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.